The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. The company's stock has climbed by 4.71% in the past month, exceeding the Medical sector's gain of 3.27% and the S&P 500's gain of 4.03%. Market participants will be closely following the financial results of Canopy Growth Corporation in its upc ...

Canopy Growth Corporation (CGC) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released o ...

In the latest market close, Canopy Growth Corporation (CGC) reached $10.85, with a -1.36% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.12%. At the same time, the Dow added 0.34%, and the tech-heavy Nasdaq lost 0.07%. Shares of the company witnessed a gain of 40.49% over the previous month, beating the performance of the Medical sector with its gain of 5.73% and the S&P 500's gain of 4.99%. The investment community will be paying close attention to ...

One of the most significant developments regarding the legalization movement came Thursday when President Biden posted a video message regarding his administration's intentions to reclassify marijuana from a Schedule I drug to Schedule III. "Too many lives have been upended because of our failed approach to marijuana," he remarked. On paper, stakeholders of cannabis operator Canopy Growth (NASDAQ:CGC) have plenty of reasons to smile. Anticipation of major marijuana policy shifts culminated in a recent annou ...

Fans of Canopy Growth (NASDAQ:CGC) stock have plenty to look forward to following a recent proposal to reschedule cannabis. This, of course, includes its upcoming first-quarter earnings report, due on May 30. The entire cannabis industry has been on cloud nine of late following the U.S. Department of Justice's (DOJ) historic proposal to move forward with the re-classification of cannabis. Indeed, on Thursday, May 16, the DOJ released a proposal to reclassify the green plant from a Schedule I drug to a Sched ...

Canopy Growth Corporation (CGC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this company have returned +40.5% over the past month versus the Zacks S&P 500 composite's +5% change. The Zacks Medical - Products industry, to which Canopy Growth belongs, has gained 3.5% over this period. Now the key question is: Where could the stock be headed in the near term? While m ...

Canopy Growth is part of the Zacks Medical - Products industry. Aurora Cannabis Inc. (ACB) , another stock in the same industry, closed the last trading session 6.9% higher at $7.61. ACB has returned 23% in the past month. Canopy Growth Corporation (CGC) shares ended the last trading session 11% higher at $11. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 52.7% gain over the past four weeks. The surge in Canopy G ...

Following the release of its fourth quarter and fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on May 30, at 10 AM Eastern Time. Webcast Information SMITHS FALLS, ON, May 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ...

Key Canadian Cannabis Stocks to Watch in Mid-May 2024 As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage ...

Pot stocks can sometimes trade like meme stocks, and investors need to be careful, or they may incur significant losses.Cannabis stocks were surging last week on the news that the Drug Enforcement Administration (DEA) is going to reclassify marijuana. It will no longer be a Schedule I drug alongside heroin and LSD. Instead, it will be moved to Schedule III, where ketamine and certain anabolic steroids are grouped.Usually, when there's some positive news around marijuana reform, shares of Tilray Brands (TLRY ...